Araris Biotech closes $24m Series A financing round
Swiss ADC maker Araris Biotech AG has added a $24m financing round to its CHF15.2m (S17.8m) seed round in 2020 to expand its portfolio of proprietary antibody drug conjugates.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1125 entries already.
Entries by Thomas Gabrielczyk
New Protein Fund I supports 17 alternative protein start-ups
/in News/by Thomas GabrielczykWith money from its $50m New Protein Fund, Big Idea Ventures funds in 17 pre-seed plant-based, cell-based and microbial food, ingredient and technology companies.
Sibylla Biotech raises 23m Series A
/in News/by Thomas GabrielczykVerona-based Sibylla Biotech has closed a 23m Series A financing round to advance its Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT) platform.
AI expert XUND GmbH bags 6m seed financing
/in News/by Thomas GabrielczykAustrian XUND GmbH wants to use the assets of a 6m seed financing to grow in Germany, Switzerland and Austria.
ADC makeer Pheon Therapeutics raises $68m
/in News/by Thomas GabrielczykAntibody-Drug Conjugate (ADC) specialist Pheon Therapeutics Ltd. has closed a $68m Series A financing co-led by Brandon Capital, Forbion and Atlas Venture.
Kupando raises 13m to push TLR4/7 agonist
/in News/by Thomas GabrielczykKupando has raised 13m in Series A financing co-led by Remiges Ventures and LifeCare Partners to initiate clinical development of KUP101.
DAMAN P/S enters personal RA medicine project
/in News/by Thomas GabrielczykDanish AI health app developer DAMAN P/S has entered the 12m EU-funded Squeeze project, that aims to find stratification biomarkers for DMARDs in rheumatoid arthritis (RA).
AI specialist Quinten Health bags 14m financing
/in News/by Thomas GabrielczykQuinten Groups French healthcare arm Quinten Health has closed a financing round to advance disease modeling platforms and virtual twins in real-world.
Bavarian Nordic expands vaccine contract by $234m
/in News/by Thomas GabrielczykBavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options.
Food specialist Standing Ovation SA raises 12m
/in News/by Thomas GabrielczykFoodtech startup Standing Ovation SA has closed an oversubscribed 12m Series A financing round led by Astanor Ventures.